Gorman Brian
- SEC CIK
- 0001813451
No open-market purchases or sales filed in the past year.
Current role at each company
- OPNT Opiant Pharmaceuticals, Inc.Other: General Counselas of Mar 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gorman Brian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 (view filing) | Jan 27 | 4 days | Gorman BrianOther: General Counsel | SSale | −444 | $20.26 | −$9.00K | −1.4%32.0K after | |
| Jan 5, 2023 (view filing) | Jan 5 | Same day | Gorman BrianOther: General Counsel | SSale | −1.31K | $20.20 | −$26.5K | −3.9%32.4K after | |
| Jul 15, 2022 (view filing) | Jul 14 | 1 day | Gorman BrianOther: General Counsel | SSale | −691 | $11.16 | −$7.71K | −2.0%33.7K after | |
| Jun 6, 2022 (view filing) | Jun 2 | 4 days | Gorman BrianOther: General Counsel | SSale | −1.15K | $13.52 | −$15.5K | −3.4%32.4K after | |
| Sep 14, 2021 (view filing) | Sep 14 | Same day | Gorman BrianOther: General Counsel | PPurchase | +1.31K | $19.04 | +$25.0K | +6.5%21.6K after | 2 lots |